Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Sophie Kornowski currently holds 36,000 shares of Maze Therapeutics, Inc. (MAZE), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Sophie Kornowski has been a net neutral trader of MAZE stock. They have purchased $0 and sold $0 worth of shares.
Sophie Kornowski's most recent insider trade was on Aug 13, 2026, when they sold 36,000 shares at $0.00 per share.
Sophie Kornowski serves as Executive at Maze Therapeutics, Inc. (MAZE). They have executed 1 insider transactions totaling $0 over their tenure at the company.
Sophie Kornowski holds the position of Executive at Maze Therapeutics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 1 years and currently hold a stake valued at $0.
Sophie Kornowski has shown a balanced trading pattern, with $0 in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a balanced approach to trading.
The largest transaction by Sophie Kornowski was on Aug 13, 2026, when they purchased $0 worth of MAZE shares. This transaction involved 36,000 shares at N/A per share.
Sophie Kornowski currently owns 36,000 shares of Maze Therapeutics, Inc. (MAZE), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Sophie Kornowski's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Sophie Kornowski has 1 Form 4 filings on record as an insider at Maze Therapeutics, Inc..
Set alerts for Sophie Kornowski and 40,000+ other insiders.